Before the infusion was complete, she died of sudden cardiac arrest. An autopsy failed to find a cause of her death, but experts were concerned that the potassium included in the hydration might have ...
This is one of those friend-of-a-friend tales, so it’s a bit short on details. But the basic story is this: A young and generally healthy man was feeling run down, so he went to a wellness spa to ...
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who ...
Morning Overview on MSN
Single dose of potent psychedelic slashes depression in clinical trial
A single intravenous infusion of DMT, a fast-acting psychedelic compound found in the Amazonian brew ayahuasca, significantly ...
After being found effective over longer durations with smaller doses, this study found that nipocalimab infusions resulted in a tolerable safety profile and remained effective even in shorter ...
While Eli Lilly’s investigational monoclonal antibody drug, bamlanivimab, just received FDA emergency approval to treat mild coronavirus patients, top officials voiced concerns over its challenging IV ...
Newborns, particularly premature infants, are highly vulnerable during intravenous infusion treatments due to their low immunity, inability to express discomfort, and fragile veins. Extravasation, the ...
MILAN -- An investigational 10-minute subcutaneous injection of ocrelizumab (Ocrevus) was non-inferior to the established IV infusion formulation of the drug in multiple sclerosis (MS), the phase III ...
Original Medicare provides coverage for IV infusion therapy when a doctor determines it to be medically necessary, both in a clinic setting and at home. Medicare Advantage (Part C) plans need to offer ...
The sizes of microplastics ranged from 1 to 62 µm, with a median of about 8.5 µm. HealthDay News — Microplastics appear to be present in filtered solutions used for medical intravenous infusions, with ...
Results were announced from a phase 3 study evaluating an investigational intramuscular (IM) formulation of ibalizumab-uiyk for the treatment of heavily treatment-experienced adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results